Revenues have been growing at an average rate of 1.4% per year. However, Achilles's earnings have been declining at an average annual rate of -46.4%, while the Chemicals industry saw earnings growing at 7.1% annually. The company had a large one-off loss of ¥1.3B impacting its last 12 months of financial results to 30th September, 2025.
Cyborg Score Rationale
Achilles faces significant profitability headwinds with earnings declining sharply while revenues grow modestly. The one-off ¥1.3B loss in FY2025, combined with weak ROE (0.5%) and net margins (0.2%), signals operational distress. Debt management remains moderate but earnings power is concerning.
Top Insights
(May 2026) FY March 2026 financial results announced; Ordinary General Meeting scheduled June 25, 2026
(February 2026) Moderate net debt to EBITDA ratio of 1.8 and strong EBIT-to-interest coverage indicate manageable debt position
(September 2025) Large one-off ¥1.3B loss impacted recent 12-month period; underlying operations remain challenged
Zero analyst coverage and low research visibility relative to market capitalization of ~¥19–21B
Named Competitors
Harima Chemicals — Japanese chemicals and materials producer
Okura Industrial — Industrial materials and chemical producer
Nippon Chemical Industrial — Chemical and industrial materials manufacturer
Recent Developments
(May 2026) FY March 2026 financial results disclosed on May 12, 2026
(June 2026) Ordinary General Meeting of Shareholders scheduled for June 25, 2026
(February 2026) Debt analysis shows moderate leverage with net debt of ¥7.32B against market cap of ¥21.4B
Open the full interactive Achilles Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.